[144] BKV Corporation SEC Filing
BKV Corporation (ticker: BKV) filed a Form 144 reporting a proposed sale of 10,000 common shares through Charles Schwab & Co., Inc. on the NYSE with an aggregate market value of $216,200. The filer shows 84,708,373 shares outstanding, and the shares to be sold were acquired as Founders Shares on 05/01/2020 from BKV Corp. The notice lists two prior sales in the past three months by Lindsay B Larrick: 10,000 shares sold on 06/02/2025 for $216,485 and 10,000 shares sold on 07/01/2025 for $231,307. The filer certifies no undisclosed material adverse information and includes broker details for the planned sale.
La BKV Corporation (simbolo: BKV) ha depositato un Modulo 144 segnalando la proposta di vendita di 10,000 azioni ordinarie tramite Charles Schwab & Co., Inc. alla NYSE, con un valore di mercato complessivo di $216,200. Il dichiarante indica 84,708,373 azioni in circolazione e precisa che le azioni da vendere sono state acquisite come Founders Shares il 05/01/2020 da BKV Corp. L'avviso riporta due vendite precedenti negli ultimi tre mesi effettuate da Lindsay B Larrick: 10,000 azioni vendute il 06/02/2025 per $216,485 e 10,000 azioni vendute il 07/01/2025 per $231,307. Il dichiarante certifica l'assenza di informazioni materiali sfavorevoli non divulgate e fornisce i dettagli del broker per la vendita pianificata.
BKV Corporation (símbolo: BKV) presentó un Formulario 144 informando la propuesta de venta de 10,000 acciones ordinarias a través de Charles Schwab & Co., Inc. en la NYSE, con un valor de mercado agregado de $216,200. El declarante indica 84,708,373 acciones en circulación, y las acciones a vender se adquirieron como Founders Shares el 05/01/2020 de BKV Corp. El aviso enumera dos ventas previas en los últimos tres meses realizadas por Lindsay B Larrick: 10,000 acciones vendidas el 06/02/2025 por $216,485 y 10,000 acciones vendidas el 07/01/2025 por $231,307. El declarante certifica que no existe información material adversa no divulgada e incluye los datos del corredor para la venta planificada.
BKV Corporation(티커: BKV)는 Form 144를 제출하여 NYSE에서 Charles Schwab & Co., Inc.을 통해 10,000 보통주를 매도할 예정이라고 보고했으며, 총 시가총액 $216,200에 해당한다고 밝혔습니다. 제출인은 84,708,373 주 발행을 기재했으며, 매도 예정 주식은 BKV Corp.로부터 Founders Shares로 05/01/2020에 취득한 것이라고 명시했습니다. 통지서에는 지난 3개월 동안 Lindsay B Larrick가 실시한 두 건의 이전 매도도 기재되어 있습니다: 06/02/2025에 10,000주를 $216,485에 매도 및 07/01/2025에 10,000주를 $231,307에 매도. 제출인은 공개되지 않은 중대한 불리한 정보가 없음을 인증하고 예정된 매도를 위한 중개인 정보를 포함했습니다.
BKV Corporation (symbole : BKV) a déposé un formulaire 144 signalant une proposition de vente de 10,000 actions ordinaires par l'intermédiaire de Charles Schwab & Co., Inc. à la NYSE, pour un valeur de marché totale de $216,200. Le déclarant indique 84,708,373 actions en circulation, et les actions à vendre ont été acquises en tant que Founders Shares le 05/01/2020 de BKV Corp. L'avis mentionne deux ventes antérieures au cours des trois derniers mois réalisées par Lindsay B Larrick : 10,000 actions vendues le 06/02/2025 pour $216,485 et 10,000 actions vendues le 07/01/2025 pour $231,307. Le déclarant certifie l'absence d'informations défavorables significatives non divulguées et fournit les coordonnées du courtier pour la vente prévue.
Die BKV Corporation (Ticker: BKV) hat ein Formular 144 eingereicht und eine geplante Veräußerung von 10,000 Stammaktien über Charles Schwab & Co., Inc. an der NYSE gemeldet, mit einem gesamten Marktwert von $216,200. Der Melder weist 84,708,373 ausstehende Aktien aus; die zum Verkauf stehenden Aktien wurden am 05/01/2020 als Founders Shares von BKV Corp. erworben. Die Mitteilung nennt zwei frühere Verkäufe innerhalb der letzten drei Monate durch Lindsay B Larrick: 10,000 Aktien am 06/02/2025 für $216,485 verkauft und 10,000 Aktien am 07/01/2025 für $231,307 verkauft. Der Melder bestätigt, dass keine nicht offengelegten, wesentlichen nachteiligen Informationen vorliegen, und enthält die Brokerangaben für den geplanten Verkauf.
- Required disclosures provided: broker details, acquisition date, class of shares, and aggregate market value are all stated
- Recent sales fully disclosed: two prior sales in the past three months include dates and gross proceeds
- Filer includes standard certification: statement that no undisclosed material adverse information exists
- Insider selling activity: filer or related person sold 10,000 shares now and disclosed two recent sales totaling 20,000 shares in the past three months
- Potential market perception risk: repeated insider sales could be viewed negatively by some investors, although the filing itself provides no reasons
Insights
TL;DR: Routine insider sale notice for 10,000 shares; prior small sales occurred in the past three months.
The Form 144 documents a proposed sale of 10,000 common shares via Charles Schwab on the NYSE with an aggregate market value of $216,200. The filing records acquisition of these shares as founders shares on 05/01/2020 and discloses two recent dispositions totaling 20,000 shares in June and July 2025 with gross proceeds of $216,485 and $231,307 respectively. For investors, these are explicit insider transactions recorded under Rule 144; the absolute sizes are modest relative to the reported 84,708,373 shares outstanding, and the filing contains the standard representation about material nonpublic information.
TL;DR: Disclosure follows Rule 144 requirements; raises routine governance transparency questions but shows no regulatory flags.
The notice provides the required broker information, the nature and date of acquisition (founders shares, 05/01/2020), and a representation that no undisclosed material adverse information exists. The record of multiple recent sales by the same person is disclosed openly, which supports transparency. The form does not include any disclaimers or indications of trading-plan reliance beyond the general Rule 10b5-1 language, so governance implications are informational rather than evidencing noncompliance.
La BKV Corporation (simbolo: BKV) ha depositato un Modulo 144 segnalando la proposta di vendita di 10,000 azioni ordinarie tramite Charles Schwab & Co., Inc. alla NYSE, con un valore di mercato complessivo di $216,200. Il dichiarante indica 84,708,373 azioni in circolazione e precisa che le azioni da vendere sono state acquisite come Founders Shares il 05/01/2020 da BKV Corp. L'avviso riporta due vendite precedenti negli ultimi tre mesi effettuate da Lindsay B Larrick: 10,000 azioni vendute il 06/02/2025 per $216,485 e 10,000 azioni vendute il 07/01/2025 per $231,307. Il dichiarante certifica l'assenza di informazioni materiali sfavorevoli non divulgate e fornisce i dettagli del broker per la vendita pianificata.
BKV Corporation (símbolo: BKV) presentó un Formulario 144 informando la propuesta de venta de 10,000 acciones ordinarias a través de Charles Schwab & Co., Inc. en la NYSE, con un valor de mercado agregado de $216,200. El declarante indica 84,708,373 acciones en circulación, y las acciones a vender se adquirieron como Founders Shares el 05/01/2020 de BKV Corp. El aviso enumera dos ventas previas en los últimos tres meses realizadas por Lindsay B Larrick: 10,000 acciones vendidas el 06/02/2025 por $216,485 y 10,000 acciones vendidas el 07/01/2025 por $231,307. El declarante certifica que no existe información material adversa no divulgada e incluye los datos del corredor para la venta planificada.
BKV Corporation(티커: BKV)는 Form 144를 제출하여 NYSE에서 Charles Schwab & Co., Inc.을 통해 10,000 보통주를 매도할 예정이라고 보고했으며, 총 시가총액 $216,200에 해당한다고 밝혔습니다. 제출인은 84,708,373 주 발행을 기재했으며, 매도 예정 주식은 BKV Corp.로부터 Founders Shares로 05/01/2020에 취득한 것이라고 명시했습니다. 통지서에는 지난 3개월 동안 Lindsay B Larrick가 실시한 두 건의 이전 매도도 기재되어 있습니다: 06/02/2025에 10,000주를 $216,485에 매도 및 07/01/2025에 10,000주를 $231,307에 매도. 제출인은 공개되지 않은 중대한 불리한 정보가 없음을 인증하고 예정된 매도를 위한 중개인 정보를 포함했습니다.
BKV Corporation (symbole : BKV) a déposé un formulaire 144 signalant une proposition de vente de 10,000 actions ordinaires par l'intermédiaire de Charles Schwab & Co., Inc. à la NYSE, pour un valeur de marché totale de $216,200. Le déclarant indique 84,708,373 actions en circulation, et les actions à vendre ont été acquises en tant que Founders Shares le 05/01/2020 de BKV Corp. L'avis mentionne deux ventes antérieures au cours des trois derniers mois réalisées par Lindsay B Larrick : 10,000 actions vendues le 06/02/2025 pour $216,485 et 10,000 actions vendues le 07/01/2025 pour $231,307. Le déclarant certifie l'absence d'informations défavorables significatives non divulguées et fournit les coordonnées du courtier pour la vente prévue.
Die BKV Corporation (Ticker: BKV) hat ein Formular 144 eingereicht und eine geplante Veräußerung von 10,000 Stammaktien über Charles Schwab & Co., Inc. an der NYSE gemeldet, mit einem gesamten Marktwert von $216,200. Der Melder weist 84,708,373 ausstehende Aktien aus; die zum Verkauf stehenden Aktien wurden am 05/01/2020 als Founders Shares von BKV Corp. erworben. Die Mitteilung nennt zwei frühere Verkäufe innerhalb der letzten drei Monate durch Lindsay B Larrick: 10,000 Aktien am 06/02/2025 für $216,485 verkauft und 10,000 Aktien am 07/01/2025 für $231,307 verkauft. Der Melder bestätigt, dass keine nicht offengelegten, wesentlichen nachteiligen Informationen vorliegen, und enthält die Brokerangaben für den geplanten Verkauf.
FAQ
What does the BKV Form 144 report?
Who is listed as the seller on the recent transactions?
When were the shares being sold originally acquired?
How many BKV shares are outstanding according to the form?
What were the gross proceeds from the recent sales disclosed?
